X. Yan

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

P. Hunziker, P. Rickenbacher, O. Bertel, 1998, Circulation.

Isradipine improves endothelium-dependent vasodilation in normotensive coronary artery disease patients with hypercholesterolemia

W. Kiowski, H. Brunner-LaRocca, F. Amann, 2001, Journal of hypertension.

Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure.

F. Follath, M. Donath, H. Brunner, 1998, The Journal of clinical endocrinology and metabolism.

Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension.

W. Kiowski, G. Sütsch, X. Yan, 1999, Journal of hypertension.

AdLTR2EF1α-FGF2-mediated prevention of fractionated irradiation-induced salivary hypofunction in swine

L. Guo, B. Baum, C. Zhang, 2014, Gene Therapy.

[Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].

D. Hu, R. Zhao, X. Yan, 2017, Zhonghua xin xue guan bing za zhi.

Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.

T. Lüscher, W. Kiowski, M. Fleisch, 2000, Journal of cardiovascular pharmacology.

Acanthopanax senticosus polysaccharide suppressing proliferation and metastasis of the human non-small cell lung cancer NCI-H520 cells is associated with Wnt/β-catenin signaling.

H. Hu, L. Luo, L. Jin, 2019, Neoplasma.